Form 8-K - Current report:
SEC Accession No. 0001193125-25-154955
Filing Date
2025-07-02
Accepted
2025-07-02 16:15:12
Documents
12
Period of Report
2025-07-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d815359d8k.htm   iXBRL 8-K 23186
  Complete submission text file 0001193125-25-154955.txt   136579

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sepn-20250701.xsd EX-101.SCH 2852
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sepn-20250701_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sepn-20250701_pre.xml EX-101.PRE 11259
14 EXTRACTED XBRL INSTANCE DOCUMENT d815359d8k_htm.xml XML 3633
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 251101188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)